Biosurfactants produced by marine microorganisms with therapeutic applications

Marine Drugs

Volumn 14, Issue 2, 2016, Pages

  Gudiña, Eduardo J ^a   Teixeira, José A ^a   Rodrigues, Lígia R ^a  

^a UNIVERSITY OF MINHO   (Portugal)

Author keywords

Anti adhesive activity; Anti biofilm activity; Antimicrobial activity; Biosurfactant; Cancer activity; Metagenomics

Indexed keywords

ALPHA GALACOSYLCERAMIDE; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; APRATOXIN A; BIOSURFACTANT; FELLUTAMIDE A; FELLUTAMIDE B; FELLUTAMIDE C; FELLUTAMIDE F; GLYCOLIPID; GLYCOLIPOPROTEIN; HALLOBACILLIN; ITURIN A; LIPOPEPTIDE; MIXIRIN; MYRMEKIOSIDE; RAKICIDIN A; RAKICIDIN B; RHAMNOLIPID; SOMOCYSTINAMIDE A; SURFACTIN; TRIKENTROSIDE; UNCLASSIFIED DRUG; SURFACTANT;

ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BACTERIAL INFECTION; CANCER INHIBITION; CANDIDA ALBICANS; DRUG CYTOTOXICITY; DRUG MECHANISM; HUMAN; IC50; MARINE SPECIES; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; STREPTOMYCES; ANIMAL; AQUATIC SPECIES; BIOFILM; DRUG DEVELOPMENT; DRUG EFFECTS; ISOLATION AND PURIFICATION; METABOLISM; METAGENOMICS; PROCEDURES;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC AGENTS; AQUATIC ORGANISMS; BIOFILMS; DRUG DISCOVERY; HUMANS; METAGENOMICS; SURFACE-ACTIVE AGENTS;

EID: 84960117696     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md14020038     Document Type: Article

References (95)

1. Bhatnagar, I.; Kim, S.K. Immense essence of excellence: Marine microbial bioactive compounds. Mar. Drugs 2010, 8, 2673-2701. [CrossRef] [PubMed]
2. Nuñez, R.; Garateix, A.; Laguna, A.; Fernández, M.D.; Ortiz, E.; Llanio, M.; Valdés, O.; Rodríguez, A.; Menéndez, R. Caribbean marine biodiversity as a source of new compounds of biomedical interest and other industrial applications. Pharmacologyonline 2006, 3, 111-119.
3. Carvalho, C.C.; Fernandes, P. Production of metabolites as bacterial responses to the marine environment. Mar. Drugs 2010, 8, 705-727. [CrossRef] [PubMed]
4. Satpute, S.K.; Banat, I.M.; Dhakephalkar, P.K.; Banpurkar, A.G.; Chopade, B.A. Biosurfactants, bioemulsifiers and exopolysaccharides from marine microorganisms. Biotechnol. Adv. 2010, 28, 436-450. [CrossRef] [PubMed]
5. Shekhar, S.; Sundaramanickam, A.; Balasubramanian, T. Biosurfactant producing microbes and their potential applications: A review. Crit. Rev. Environ. Sci. Technol. 2015, 45, 1522-1554. [CrossRef]
6. Ramiah, N. Facets and opportunities. In Marine Microbiology; Ramaiah, N., Ed.; National Institute of Oceanography: Goa, India, 2005; pp. 1-6.
7. Gudiña, E.J.; Rangarajan, V.; Sen, R.; Rodrigues, L.R. Potential therapeutic applications of biosurfactants. Trends Pharmacol. Sci. 2013, 34, 667-675. [CrossRef] [PubMed]
8. Marchant, R.; Banat, I.M. Microbial biosurfactants: Challenges and opportunities for future exploitation. Trends Biotechnol. 2012, 30, 558-565. [CrossRef] [PubMed]
9. Banat, I.M.; Makkar, R.S.; Cameotra, S.S. Potential commercial applications of microbial surfactants. Appl. Microbiol. Biotechnol. 2000, 53, 495-508. [CrossRef] [PubMed]
10. Edwards, K.R.; Lepo, J.E.; Lewis, M.A. Toxicity comparison of biosurfactants and synthetic surfactants used in oil spill remediation to two estuarine species. Mar. Pollut. Bull. 2003, 46, 1309-1316. [CrossRef]
11. Poremba, K.; Gunkel, W.; Lang, S.; Wagner, F. Toxicity testing of synthetic and biogenic surfactants on marine microorganisms. Environ. Toxicol. Water Qual. 1991, 6, 157-163. [CrossRef]
12. Poremba, K.; Gunkel, W.; Lang, S.; Wagner, F. Marine biosurfactants, III. Toxicity testing with marine microorganisms and comparison with synthetic detergents. Z. Naturforsch. C 1991, 46, 210-216. [PubMed]
13. Fracchia, L.; Cavallo, M.; Martinotti, M.G.; Banat, I.M. Biosurfactants and bioemulsifiers biomedical and related applications: Present status and future potentials. In Biomedical Science, Engineering and Technology; Ghista, D.N., Ed.; InTech: Rijeka, Croatia, 2012; pp. 325-370.
14. Ibacache-Quiroga, C.; Ojeda, J.; Espinoza-Vergara, G.; Olivero, P.; Cuellar, M.; Dinamarca, M.A. The hydrocarbon-degrading marine bacterium Cobetia sp. strain MM1IDA2H-1 produces a biosurfactant that interferes with quorum sensing of fish pathogens by signal hijacking. Microb. Biotechnol. 2013, 6, 394-405. [CrossRef] [PubMed]
15. Yan, X.; Sims, J.; Wang, B.; Hamann, M.T. Marine actinomycete Streptomyces sp. ISP2-49E, a new source of rhamnolipid. Biochem. Syst. Ecol. 2014, 55, 292-295. [CrossRef] [PubMed]
16. Abraham, W.R.; Meyer, H.; Yakimov, M. Novel glycine containing glucolipids from the alkane using bacterium Alcanivorax borkumensis. Biochim. Biophys. Acta 1998, 1393, 57-62. [CrossRef]
17. Banat, I.M. The isolation of a thermophilic biosurfactant producing Bacillus sp. Biotechnol. Lett. 1993, 15, 591-594. [CrossRef]
18. Hamed, S.B.; Smii, L.; Ghram, A.; Maaroufi, A. Screening of potential biosurfactant-producing bacteria isolated from seawater biofilm. Afr. J. Biotechnol. 2012, 11, 14153-14158.
19. Harayama, S.; Kasai, Y.; Hara, A. Microbial communities in oil-contaminated seawater. Curr. Opin. Biotechnol. 2004, 15, 205-214. [CrossRef] [PubMed]
20. Stein, J.L.; Marsh, T.L.; Wu, K.Y.; Shizuya, H.; DeLong, E.F. Characterization of uncultivated prokaryotes: Isolation and analysis of a 40-kilobase-pair genome fragment from a planktonic marine archaeon. J. Bacteriol. 1996, 178, 591-599. [PubMed]
21. Coates, A.R.M.; Halls, G.; Hu, Y. Novel classes of antibiotics or more of the same? Br. J. Pharmacol. 2011, 163, 184-194. [CrossRef] [PubMed]
22. Benincasa, M.; Abalos, A.; Oliveira, I.; Manresa, A. Chemical structure, surface properties and biological activities of biosurfactant produced by Pseudomonas aeruginosa LBI from soapstock. Antonie Van Leeuwenhoek 2004, 85, 1-8. [CrossRef] [PubMed]
23. Haba, E.; Pinazo, A.; Jauregui, O.; Espuny, M.J.; Infante, M.R.; Manresa, A. Physicochemical characterization and antimicrobial properties of rhamnolipids produced by Pseudomonas aeruginosa 47T2 NCBIM 40044. Biotechnol. Bioeng. 2003, 81, 316-322. [CrossRef] [PubMed]
24. Rodrigues, L.R.; Banat, I.M.; Teixeira, J.A.; Oliveira, R. Biosurfactants: Potential applications in medicine. J. Antimicrob. Chemother. 2006, 57, 609-618. [CrossRef] [PubMed]
25. Rodrigues, L.R. Inhibition of bacterial adhesion on medical devices. In Bacterial Adhesion: Biology, Chemistry, and Physics, Series: Advances in Experimental Medicine and Biology; Linke, D., Goldman, A., Eds.; Springer: Berlin, Germany, 2011; Volume 715, pp. 351-367.
26. Jackson, S.A.; Borchert, E.; O'Gara, F.; Dobson, A.D.W. Metagenomics for the discovery of novel biosurfactants of environmental interest from marine ecosystems. Curr. Opin. Biotechnol. 2015, 33, 176-182. [CrossRef] [PubMed]
27. Kiran, G.S.; Sabarathnam, B.; Selvin, J. Biofilm disruption potential of a glycolipid biosurfactant from marine Brevibacterium casei. FEMS Immunol. Med. Microbiol. 2010, 59, 432-438. [CrossRef] [PubMed]
28. Dusane, D.H.; Pawar, V.S.; Nancharaiah, Y.V.; Venugopalan, V.P.; Kumar, A.R.; Zinjarde, S.S. Anti-biofilm potential of a glycolipid surfactant produced by a tropical marine strain of Serratia marcescens. Biofouling 2011, 27, 645-654. [CrossRef] [PubMed]
29. Khopade, A.; Ren, B.; Liu, X.Y.; Mahadik, K.; Zhang, L.; Kokare, C. Production and characterization of biosurfactant from marine Streptomyces species B3. J. Colloid Interface Sci. 2012, 367, 311-318. [CrossRef] [PubMed]
30. Manivasagan, P.; Sivasankar, P.; Venkatesan, J.; Sivakumar, K.; Kim, S.K. Optimization, production and characterization of glycolipid biosurfactant from the marine actinobacterium, Streptomyces sp. MAB36. Bioprocess Biosyst. Eng. 2014, 37, 783-797. [CrossRef] [PubMed]
31. Kiran, G.S.; Hema, T.A.; Gandhimathi, R.; Selvin, J.; Thomas, T.A.; Ravji, T.R.; Natarajaseenivasan, K. Optimization and production of a biosurfactant from the sponge-associated marine fungus Aspergillus ustus MSF3. Colloids Surf. B Biointerfaces 2009, 73, 250-256. [CrossRef] [PubMed]
32. Das, P.; Mukherjee, S.; Sen, R. Antimicrobial potential of a lipopeptide biosurfactant derived from a marine Bacillus circulans. J. Appl. Microbiol. 2008, 104, 1675-1684. [CrossRef] [PubMed]
33. Das, P.; Mukherjee, S.; Sen, R. Antiadhesive action of a marine microbial surfactant. Colloids Surf. B Biointerfaces 2009, 71, 183-186. [CrossRef] [PubMed]
34. Sivapathasekaran, C.; Mukherjee, S.; Samanta, R.; Sen, R. High-performance liquid chromatography purification of biosurfactant isoforms produced by a marine bacterium. Anal. Bioanal. Chem. 2009, 395, 845-854. [CrossRef] [PubMed]
35. Lawrance, A.; Balakrishnan, M.; Joseph, T.C.; Sukumaran, D.P.; Valsalan, V.N.; Gopal, D.; Ramalingam, K. Functional and molecular characterization of a lipopeptide surfactant from the marine sponge-associated eubacteria Bacillus licheniformis NIOT-AMKV06 of Andaman and Nicobar Islands, India. Mar. Pollut. Bull. 2014, 82, 76-85. [CrossRef] [PubMed]
36. Kiran, G.S.; Thomas, T.A.; Selvin, J.; Sabarathnam, B.; Lipton, A.P. Optimization and characterization of a new lipopeptide biosurfactant produced by marine Brevibacterium aureum MSA13 in solid state culture. Bioresour. Technol. 2010, 101, 2389-2396. [CrossRef] [PubMed]
37. Gandhimathi, R.; Kiran, G.S.; Hema, T.A.; Selvin, J.; Raviji, T.R.; Shanmughapriya, S. Production and characterization of lipopeptide biosurfactant by a sponge-associated marine actinomycetes Nocardiopsis alba MSA10. Bioprocess Biosyst. Eng. 2009, 32, 825-835. [CrossRef] [PubMed]
38. Selvin, J.; Shanmughapriya, S.; Gandhimathi, R.; Kiran, G.S.; Ravji, T.R. Optimization and production of novel antimicrobial agents from sponge associated marine actinomycetes Nocardiopsis dassonvillei MAD08. Appl. Microbiol. Biotechnol. 2009, 83, 435-445. [CrossRef] [PubMed]
39. Das, P.; Mukherjee, S.; Sen, R. Substrate dependent production of extracellular biosurfactant by a marine bacterium. Bioresour. Technol. 2009, 100, 1015-1019. [CrossRef] [PubMed]
40. Costa, S.G.V.A.O.; Déziel, E.; Lépine, F. Characterization of rhamnolipid production by Burkholderia glumae. Lett. Appl. Microbiol. 2011, 53, 620-627. [CrossRef] [PubMed]
41. Hosková, M.; Schreiberová, O.; Jezdík, R.; Chudoba, J.; Masák, J.; Sigler, K.; Rezanka, T. Characterization of rhamnolipids produced by non-pathogenic Acinetobacter and Enterobacter bacteria. Bioresour. Technol. 2013, 130, 510-516. [CrossRef] [PubMed]
42. Toribio, J.; Escalante, A.E.; Soberón-Chávez, G. Rhamnolipids: Production in bacteria other than Pseudomonas aeruginosa. Eur. J. Lipid Sci. Technol. 2010, 112, 1082-1087. [CrossRef]
43. Wittgens, A.; Tiso, T.; Arndt, T.T.; Wenk, P.; Hemmerich, J.; Müller, C. Growth independent rhamnolipid production from glucose using the non-pathogenic Pseudomonas putida KT2440. Microb. Cell Fact. 2011, 10, 80. [CrossRef] [PubMed]
44. Tavares, L.F.D.; Silva, P.M.; Junqueira, M.; Mariano, D.C.O.; Nogueira, F.C.S.; Domont, G.B. Characterization of rhamnolipids produced by wild-type and engineered Burkholderia kururiensis. Appl. Microbiol. Biotechnol. 2013, 97, 1909-1921. [CrossRef] [PubMed]
45. Siegel, R.L.; Miller, K.D.; Jemal, A. Cancer Statistics, 2015. CA Cancer J. Clin. 2015, 65, 5-29. [CrossRef] [PubMed]
46. Bolhassani, A. Cancer chemoprevention by natural carotenoids as an efficient strategy. Anticancer Agents Med. Chem. 2015, 15, 1026-1031. [CrossRef] [PubMed]
47. Cragg, G.M.; Newman, D.J. Plants as a source of anti-cancer agents. J. Ethnopharmacol. 2005, 100, 72-79. [CrossRef] [PubMed]
48. Madadi, N.R.; Zong, H.; Ketkar, A.; Zheng, C.; Penthala, N.R.; Janganati, V.; Bommagani, S.; Eoff, R.L.; Guzmanb, M.L.; Crooks, P.A. Synthesis and evaluation of a series of resveratrol analogues as potent anti-cancer agents that target tubulin. MedChemComm 2015, 6, 788-794. [CrossRef] [PubMed]
49. Kaur, G.; Verma, N. Nature curing cancer-Review on structural modification studies with natural active compounds having anti-tumor efficiency. Biotechnol. Rep. 2015, 6, 64-78. [CrossRef]
50. Janakiram, N.B.; Mohammed, A.; Rao, C.V. Sea cucumbers metabolites as potent anti-cancer agents. Mar. Drugs 2015, 13, 2909-2923. [CrossRef] [PubMed]
51. Sawadogo, W.R.; Boly, R.; Cerella, C.; Teiten, M.H.; Dicato, M.; Diederich, M. A survey of marine natural compounds and their derivatives with anti-cancer activity reported in 2012. Molecules 2015, 20, 7097-7142. [CrossRef] [PubMed]
52. Niraula, N.P.; Kim, S.H.; Sohng, J.K.; Kim, E.S. Biotechnological doxorubicin production: Pathway and regulation engineering of strains for enhanced production. Appl. Microbiol. Biotechnol. 2010, 87, 1187-1194. [CrossRef] [PubMed]
53. Dey, G.; Bharti, R.; Sen, R.; Mandal, M. Microbial amphiphiles: A class of promising new-generation anticancer agents. Drug. Discov. 2015, 20, 136-146. [CrossRef] [PubMed]
54. Janek, T.; Krasowska, A.; Radwanska, A.; Lukaszewicz, M. Lipopeptide biosurfactant pseudofactin II induced apoptosis of melanoma A375 cells by specific interaction with the plasma membrane. PLoS ONE 2013, 8, e57991. [CrossRef] [PubMed]
55. Sivapathasekaran, C.; Das, P.; Mukherjee, S.; Saravanakumar, J.; Mandal, M.; Sen, R. Marine bacterium derived lipopeptides: Characterization and cytotoxic activity against cancer cell lines. Int. J. Pept. Res. Ther. 2010, 16, 215-222. [CrossRef]
56. Liu, X.; Tao, X.; Zou, A.; Yang, S.; Zhang, L.; Mu, B. Effect of the microbial lipopeptide on tumor cell lines: Apoptosis induced by disturbing the fatty acid composition of cell membrane. Protein Cell 2010, 1, 584-594. [CrossRef] [PubMed]
57. Park, S.Y.; Kim, J.H.; Lee, Y.J.; Lee, S.J.; Kim, Y. Surfactin suppresses TPA-induced breast cancer cell invasion through the inhibition of MMP-9 expression. Int. J. Oncol. 2013, 42, 287-296. [PubMed]
58. Cao, X.H.; Wang, A.H.; Jiao, R.Z.; Wang, C.L.; Mao, D.Z.; Yan, L.; Zeng, B. Surfactin induces apoptosis and G(2)/M arrest in human breast cancer MCF-7 cells through cell cycle factor regulation. Cell Biochem. Biophys. 2009, 55, 163-171. [CrossRef] [PubMed]
59. Kim, S.Y.; Kim, J.Y.; Kim, S.H.; Bae, H.J.; Yi, H.; Yoon, S.H.; Koo, B.S.; Kwon, M.; Cho, J.Y.; Lee, C.E.; Hong, S. Surfactin from Bacillus subtilis displays anti-proliferative effect via apoptosis induction, cell cycle arrest and survival signaling suppression. FEBS Lett. 2007, 581, 865-871. [CrossRef] [PubMed]
60. Das, P.; Sarkar, S.; Mandal, M.; Sen, R. Green surfactant of marine origin exerting a cytotoxic effect on cancer cell lines. RSC Adv. 2015, 5, 53086-53094. [CrossRef]
61. Dey, G.; Bharti, R.; Dhanarajan, G.; Das, S.; Dey, K.K.; Kumar, B.N.P.; Sen, R.; Mandal, M. Marine lipopeptide Iturin A inhibits Akt mediated GSK3β and FoxO3α signaling and triggers apoptosis in breast cancer. Sci. Rep. 2015, 5, 10316. [CrossRef] [PubMed]
62. Trischman, J.A.; Jensen, P.R.; Fenical, W. Halobacillin-A cytotoxic cyclic acylpeptide of the iturin class produced by a marine Bacillus. Tetrahedron Lett. 1994, 35, 5571-5574. [CrossRef]
63. Zhang, H.L.; Hua, H.M.; Pei, Y.H.; Yao, X.S. Three new cytotoxic cyclic acylpeptides from marine Bacillus sp. Chem. Pharm. Bull. 2004, 52, 1029-1030. [CrossRef] [PubMed]
64. Suyama, T.L.; Gerwick, W.H. Stereospecific total synthesis of somocystinamide A. Org. Lett. 2008, 10, 4449-4452. [CrossRef] [PubMed]
65. Lee, Y.M.; Dang, H.T.; Hong, J.; Lee, C.O.; Bae, K.S.; Kim, D.K.; Jung, J.H. A cytotoxic lipopeptide from the sponge-derived fungus Aspergillus versicolor. Bull. Korean Chem. Soc. 2010, 31, 205-208. [CrossRef]
66. Lee, Y.M.; Dang, H.T.; Li, J.; Zhang, P.; Hong, J.; Lee, C.O.; Jung, J.H. A cytotoxic fellutamide analogue from the sponge-derived fungus Aspergillus versicolor. Bull. Korean Chem. Soc. 2011, 32, 3817-3820. [CrossRef]
67. Shigemori, H.; Wakuri, S.; Yazawa, K.; Nakamura, T.; Sasaki, T.; Kobayashi, J. Fellutamide-A and fellutamide-B, cytotoxic peptides from a marine fish-possessing fungus Penicillium fellutanum. Tetrahedron 1991, 47, 8529-8534. [CrossRef]
68. Poulsen, T.B. A concise route to the macrocyclic core of the rakicidins. Chem. Commun. (Camb.) 2011, 47, 12837-12839. [CrossRef] [PubMed]
69. Takeuchi, M.I. Rakicidin A effectively induces apoptosis in hypoxia adapted Bcr-Abl positive leukemic cells. Cancer Sci. 2011, 102, 591-596. [CrossRef] [PubMed]
70. Xie, J.J.; Zhou, F.; Li, E.M.; Jiang, H.; Du, Z.P.; Lin, R.; Fang, D.S.; Xu, L.Y. FW523-3, a novel lipopeptide compound, induces apoptosis in cancer cells. Mol. Med. Rep. 2011, 4, 759-763. [PubMed]
71. Yamazaki, Y.; Kunimoto, S.; Ikeda, D. Rakicidin A: A hypoxia-selective cytotoxin. Biol. Pharm. Bull. 2007, 30, 261-265. [CrossRef] [PubMed]
72. Wilson, W.R.; Hay, M.P. Targeting hypoxia in cancer therapy. Nat. Rev. Cancer 2011, 11, 393-410. [CrossRef] [PubMed]
73. Chen, Q.Y.; Liu, Y.; Luesch, H. Systematic chemical mutagenesis identifies a potent novel apratoxin A/E hybrid with improved in vivo antitumor activity. ACS Med. Chem. Lett. 2011, 2, 861-865. [CrossRef] [PubMed]
74. Nunnery, J.K.; Meyers, E.; Gerwick, W.H. Biologically active secondary metabolites from marine cyanobacteria. Curr. Opin. Biotechnol. 2010, 21, 787-793. [CrossRef] [PubMed]
75. Robertson, B.D.; Wengryniuk, S.E.; Coltart, D.M. Asymmetric total synthesis of apratoxin D. Org. Lett. 2012, 14, 5192-5195. [CrossRef] [PubMed]
76. Thornburg, C.C.; Cowley, E.S.; Sikorska, J.; Shaala, L.A.; Ishmael, J.E.; Youssef, D.T.; McPhail, K.L. Apratoxin H and apratoxin A sulfoxide from the Red Sea cyanobacterium Moorea producens. J. Nat. Prod. 2013, 76, 1781-1788. [CrossRef] [PubMed]
77. Tidgewell, K.; Engene, N.; Byrum, T.; Media, J.; Doi, T.; Valeriote, F.A.; Gerwick, W.H. Evolved diversification of a modular natural product pathway: Apratoxins F and G, two cytotoxic cyclic depsipeptides from a Palmyra collection of Lyngbya bouillonii. ChemBioChem 2010, 11, 1458-1466. [CrossRef] [PubMed]
78. Wrasidlo, W.; Mielgo, A.; Torres, V.A.; Barbero, S.; Stoletov, K.; Suyama, T.L.; Klemke, R.L.; Gerwick, W.H.; Carson, D.A.; Stupack, D.G. The marine lipopeptide somocystinamide A triggers apoptosis via caspase 8. Proc. Natl. Acad. Sci. USA 2008, 105, 2313-2318. [CrossRef] [PubMed]
79. Karanth, N.G.K.; Deo, P.G.; Veenanadig, N.K. Microbial production of biosurfactants and their importance. Curr. Sci. 1999, 77, 116-126.
80. Fuji, N.; Ueda, Y.; Fujiwara, H.; Toh, T.; Yoshimura, T.; Yamagishi, H. Antitumor effect of alphagalactosylceramide (KRN7000) on spontaneous hepatic metastases requires endogenous interleukin 12 in the liver. Clin. Cancer Res. 2000, 6, 3380-3387. [PubMed]
81. Hayakawa, Y.; Takeda, K.; Yagita, H.; Kakuta, S.; Iwakura, Y.; Van Kaer, L.; Saiki, I.; Okumura, K. Critical contribution of IFN-gamma and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of alpha-galactosylceramide. Eur. J. Immunol. 2001, 31, 1720-1727. [CrossRef]
82. Nakui, M.; Ohta, A.; Sekimoto, M.; Sato, M.; Iwakabe, K.; Yahata, T.; Kitamura, H.; Koda, T.; Kawano, T.; Makuuchi, H.; et al. Potentiation of antitumor effect of NKT cell ligand, alpha-galactosylceramide by combination with IL-12 on lung metastasis of malignant melanoma cells. Clin. Exp. Metastasis 2000, 18, 147-153. [CrossRef] [PubMed]
83. Schneiders, F.L.; Scheper, R.J.; von Blomberg, B.M.; Woltman, A.M.; Janssen, H.L.; van den Eertwegh, A.J.; Verheul, H.M.; de Gruijl, T.D.; van der Vliet, H.J. Clinical experience with alpha-galactosylceramide (KRN7000) in patients with advanced cancer and chronic hepatitis B/C infection. Clin. Immunol. 2011, 140, 130-141. [CrossRef] [PubMed]
84. Farokhi, F.; Wielgosz-Collin, G.; Robic, A.; Debitus, C.; Malleter, M.; Roussakis, C.; Kornprobst, J.M.; Barnathan, G. Antiproliferative activity against human non-small cell lung cancer of two O-alkyl-diglycosylglycerols from the marine sponges Myrmekioderrna dendyi and Trikentrion laeve. Eur. J. Med. Chem. 2012, 49, 406-410. [CrossRef] [PubMed]
85. Felczykowska, A.; Bloch, S.K.; Nejman-Falenczyk, B.; Baranska, S. Metagenomic approach in the investigation of new bioactive compounds in the marine environment. Acta Biochim. Pol. 2012, 59, 501-505. [PubMed]
86. Kennedy, J.; Flemer, B.; Jackson, S.A.; Lejon, D.P.H.; Morrissey, J.P.; O'Gara, F.; Dobson, A.D.W. Marine metagenomics: New tools for the study and exploitation of marine microbial metabolism. Mar. Drugs 2010, 8, 608-628. [CrossRef] [PubMed]
87. Kennedy, J.; O'Leary, N.D.; Kiran, G.S.; Morrissey, J.P.; O'Gara, F.; Selvin, J.; Dobson, A.D.W. Functional metagenomic strategies for the discovery of novel enzymes and biosurfactants with biotechnological applications from marine ecosystems. J. Appl. Microbiol. 2011, 111, 787-799. [CrossRef] [PubMed]
88. Coughlan, L.M.; Cotter, P.D.; Hill, C.; Alvarez-Ordóñez, A. Biotechnological applications of functional metagenomics in the food and pharmaceutical industries. Front. Microbiol. 2015, 6, 672. [CrossRef] [PubMed]
89. Biver, S.; Steels, S.; Portetelle, D.; Vandenbol, M. Bacillus subtilis as a tool for screening soil metagenomic libraries for antimicrobial activities. J. Microbiol. Biotechnol. 2013, 23, 850-855. [CrossRef] [PubMed]
90. Iqbal, H.A.; Craig, J.W.; Brady, S.F. Antibacterial enzymes from the functional screening of metagenomic libraries hosted in Ralstonia metallidurans. FEMS Microbiol. Lett. 2014, 354, 19-26. [CrossRef] [PubMed]
91. McMahon, M.D.; Guan, C.; Handelsman, J.; Thomas, M.G. Metagenomic analysis of Streptomyces lividans reveals host-dependent functional expression. Appl. Environ. Microbiol. 2012, 78, 3622-3629. [CrossRef] [PubMed]
92. Sen, R. Surfactin: Biosynthesis, genetics and potential applications. Adv. Exp. Med. Biol. 2010, 672, 316-323. [PubMed]
93. Yang, H.; Yu, H.; Shen, Z. A novel high-throughput and quantitative method based on visible color shifts for screening Bacillus subtilis THY-15 for surfactin production. J. Ind. Microbiol. Biotechnol. 2015, 42, 1139-1147. [CrossRef] [PubMed]
94. Siegmund, I.; Wagner, F. New method for detecting rhamnolipids excreted by Pseudomonas species during growth on mineral agar. Biotechnol. Tech. 1991, 5, 265-268. [CrossRef]
95. Burch, A.Y.; Shimada, B.K.; Browne, P.J.; Lindow, S.E. Novel high-throughput detection method to assess bacterial surfactant production. Appl. Environ. Microbiol. 2010, 76, 5363-5372. [CrossRef] [PubMed]